0


阿片类药物基因组学:不仅仅是代谢

Opioid Pharmacogenomics: More Than Metabolism
课程网址: http://videolectures.net/mdo2014_somogyi_opioid_pharmacogenomics/  
主讲教师: Andrew Somogyi
开课单位: 阿德莱德大学
开课时间: 2010-07-21
课程语种: 英语
中文简介:
一些阿片类药物如可待因被认为是前药,因为它们被高度多态性的CYP2D6代谢为更有效的阿片类药物,具有临床疗效和毒理学后遗症。许多阿片类药物也由CYP3A4/5代谢。在600多名使用芬太尼贴片的癌症患者中,血浆芬太尼浓度和代谢率(norfentanyl/fentanyl)与CYP3A4*22和CYP3A5*3基因型相关,但它们对变异性的总体贡献小于1%。药效学变异体的药物基因组学研究仍然是一个缺乏研究的领域;对于阿片类药物,OPRM1功能降低的A118G变异体似乎在导致疼痛患者阿片类药物剂量变异性方面不起主要作用,这可能是由于大多数研究中的低频率(<15%)和低患者数量所致。在新加坡接受剖腹产手术的950多名中国、马来和印度妇女中,A118G变异频率超过40%,吗啡PCA需求量与G变异等位基因显著相关,强调需要纳入多民族人群。由于阿片类药物也通过先天免疫介导的机制引起神经炎症,在上述两项研究(癌症芬太尼和手术吗啡)中,阿片类药物需求与TLR4和一些促炎细胞因子基因变异相关,且呈种族依赖性。为了将这一科学潜在地转化为临床,我们需要超越处置性药物基因组学,将药物靶点和细胞内信号通路遗传学纳入我们的研究,并认识到包括多个种族群体可能增加我们对导致阿片类药物疗效变异的因素的理解。
课程简介: Several opioids such as codeine are considered pro-drugs as they are metabolized by the highly polymorphic CYP2D6 to more potent opioids with clinical efficacy and toxicological sequelae. Many opioids are also metabolised by CYP3A4/5. In over 600 cancer patients using fentanyl patches, plasma fentanyl concentrations and the metabolic ratio (norfentanyl/fentanyl) were associated with CYP3A4*22 and CYP3A5*3 genotypes but their overall contribution to variability was < 1%. Pharmacogenomic studies on pharmacodynamic variants remain a poorly investigated field; for opioids, the OPRM1 reduced function A118G variant seems not to play a major role in contributing to the variability in opioid dosage in pain patients, possibly due to low frequency (<15%) and low patient numbers in most studies. In over 950 Chinese, Malay and Indian women undergoing caesarean section in Singapore, in whom the A118G variant frequency is over 40%, morphine PCA requirements were significantly related to the G variant allele, highlighting the need to include multiethnic cohorts. As opioids also cause neuroinflammation via innate immune-mediated mechanisms, in both of the above studies (cancer-fentanyl and surgery-morphine), opioid requirements were associated with variants in TLR4 and some of the proinflammatory cytokine gene variants, in an ethnicity-dependent manner. To potentially translate the science into the clinic, we need to look beyond dispositional pharmacogenomics and incorporate drug target and intracellular signaling pathway genetics into our studies and appreciate that including multiple ethnic cohorts may increase our understanding of factors contributing to variability in opioid efficacy.
关 键 词: 阿片类药物; 基因; 代谢
课程来源: 视频讲座网
数据采集: 2020-12-28:yxd
最后编审: 2021-09-20:zyk
阅读次数: 72